Beijing Tide Pharmaceutical Co., Ltd

This study tests an oral drug called TDI01 in 60 adults with moderate to severe chronic graft-versus-host disease (GVHD), a complication of stem cell transplants. Participants have already tried 1 to 5 other treatments without success. The trial has two phases: the first checks s…